Regions Financial Corp Novartis Ag Transaction History

Regions Financial Corp

  • $13.5 Billion
  • Q4 2024

A detailed history of Regions Financial Corp transactions in Novartis Ag stock. As of the latest transaction made, Regions Financial Corp holds 6,013 shares of NVS stock, worth $658,182. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,013
Previous 5,908 1.78%
Holding current value
$658,182
Previous $679,000 13.84%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$96.78 - $117.18 $10,161 - $12,303
105 Added 1.78%
6,013 $585,000
Q3 2024

Nov 14, 2024
BUY
$106.13 - $120.89 $4,032 - $4,593
38 Added 0.65%
5,908 $679,000
Q2 2024

Jul 31, 2024
SELL
$92.57 - $107.37 $50,820 - $58,946
-549 Reduced 8.55%
5,870 $624,000
Q1 2024

Apr 23, 2024
BUY
$95.27 - $108.47 $1,238 - $1,410
13 Added 0.2%
6,419 $620,000
Q4 2023

Feb 06, 2024
SELL
$92.27 - $101.54 $3,783 - $4,163
-41 Reduced 0.64%
6,406 $646,000
Q3 2023

Nov 01, 2023
BUY
$94.73 - $105.13 $73,415 - $81,475
775 Added 13.66%
6,447 $656,000
Q2 2023

Aug 09, 2023
SELL
$92.52 - $104.91 $63,931 - $72,492
-691 Reduced 10.86%
5,672 $572,000
Q1 2023

May 12, 2023
SELL
$80.03 - $92.81 $7,442 - $8,631
-93 Reduced 1.44%
6,363 $585,000
Q4 2022

Feb 03, 2023
SELL
$75.55 - $92.52 $21,607 - $26,460
-286 Reduced 4.24%
6,456 $585,000
Q3 2022

Nov 03, 2022
SELL
$74.61 - $87.26 $121,688 - $142,321
-1,631 Reduced 19.48%
6,742 $513,000
Q2 2022

Jul 25, 2022
SELL
$80.52 - $93.75 $2.41 Million - $2.81 Million
-29,983 Reduced 78.17%
8,373 $708,000
Q1 2022

Apr 25, 2022
BUY
$80.11 - $90.62 $90,764 - $102,672
1,133 Added 3.04%
38,356 $3.37 Million
Q4 2021

Jan 31, 2022
SELL
$79.7 - $88.13 $136,446 - $150,878
-1,712 Reduced 4.4%
37,223 $3.26 Million
Q3 2021

Nov 04, 2021
BUY
$81.78 - $95.14 $102,061 - $118,734
1,248 Added 3.31%
38,935 $3.18 Million
Q2 2021

Jul 27, 2021
BUY
$85.24 - $94.15 $1.07 Million - $1.18 Million
12,536 Added 49.84%
37,687 $3.44 Million
Q1 2021

Jun 02, 2021
SELL
$83.5 - $98.47 $1.04 Million - $1.23 Million
-12,481 Reduced 33.17%
25,151 $2.15 Million
Q4 2020

Feb 05, 2021
SELL
$78.07 - $94.43 $530,485 - $641,651
-6,795 Reduced 15.29%
37,632 $3.55 Million
Q3 2020

Oct 15, 2020
SELL
$82.14 - $91.0 $680,612 - $754,026
-8,286 Reduced 15.72%
44,427 $3.86 Million
Q2 2020

Jul 27, 2020
BUY
$80.93 - $91.1 $462,595 - $520,727
5,716 Added 12.16%
52,713 $4.6 Million
Q1 2020

Apr 29, 2020
SELL
$70.67 - $99.01 $64,804 - $90,792
-917 Reduced 1.91%
46,997 $3.88 Million
Q4 2019

Feb 03, 2020
BUY
$84.35 - $95.37 $462,153 - $522,532
5,479 Added 12.91%
47,914 $4.54 Million
Q3 2019

Oct 24, 2019
SELL
$85.54 - $94.26 $17,108 - $18,852
-200 Reduced 0.47%
42,435 $3.69 Million
Q2 2019

Jul 19, 2019
BUY
$75.4 - $92.8 $40,866 - $50,297
542 Added 1.29%
42,635 $3.89 Million
Q1 2019

Apr 19, 2019
SELL
$75.32 - $86.15 $426,913 - $488,298
-5,668 Reduced 11.87%
42,093 $4.05 Million
Q4 2018

Jan 28, 2019
BUY
$73.66 - $82.02 $281,970 - $313,972
3,828 Added 8.71%
47,761 $4.1 Million
Q3 2018

Oct 22, 2018
BUY
$66.94 - $77.43 $100,276 - $115,990
1,498 Added 3.53%
43,933 $3.79 Million
Q2 2018

Jul 26, 2018
SELL
$64.91 - $73.36 $660,589 - $746,584
-10,177 Reduced 19.34%
42,435 $3.21 Million
Q1 2018

Apr 18, 2018
BUY
$70.39 - $84.15 $194,276 - $232,254
2,760 Added 5.54%
52,612 $4.25 Million
Q4 2017

Jan 18, 2018
BUY
$72.33 - $77.64 $535,820 - $575,157
7,408 Added 17.45%
49,852 $4.19 Million
Q3 2017

Oct 23, 2017
BUY
$74.14 - $77.27 $3.15 Million - $3.28 Million
42,444
42,444 $3.64 Million

Others Institutions Holding NVS

# of Institutions
1,490
Shares Held
131M
Call Options Held
1.31M
Put Options Held
1.56M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $235B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Regions Financial Corp Portfolio

Follow Regions Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regions Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Regions Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email